Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

Pfizer and BioNTech Omicron vaccine delayed

February 18, 2022 Medical Communications

The delivery of Pfizer and BioNTech SE’s vaccine, targeted specifically towards the Omicron COVID-19 variant has been delayed by several …
News

NHS bosses call for free COVID-19 tests and isolation to remain

February 18, 2022 Medical Communications

NHS bosses have called for free COVID-19 testing to remain, in spite of speculation that this could be scrapped. Boris …
News

Trial paused for respiratory virus vaccine in pregnant women

February 18, 2022 Medical Communications

GlaxoSmithKline (GSK) has hit pause on a Phase III clinical trial on safety grounds. The late-stage trial for GSK’s vaccine …
News

Astellas and Seagen announce results of study into muscle-invasive bladder cancer

February 15, 2022 Medical Communications

Astellas Pharma and Seagen announced the initial results from Cohort H of their EV-103 trial. This investigated PADDCEV (enfortumab vedotin-ejfv) …
News

NICE recommends new diagnostic devices for men with suspected prostate cancer

February 15, 2022 Medical Communications

NICE have recommended four new diagnostic devices for men with suspected prostate cancer, which reduce the chances of biopsy related …
News

Risk of new heart problems raised after COVID-19

February 11, 2022 Medical Communications

A large study has found that long after recovery from COVID-19, people continue to face significantly higher risks for new …
News

Novavax COVID-19 vaccine meets trial endpoints

February 11, 2022 Medical Communications

Novavax has announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, achieved its primary effectiveness endpoint in the paediatric expansion …
News

Sickest patients face record long waits for hospital bed

February 11, 2022 Medical Communications

According to NHS data, the sickest patients are facing record long waits for a bed upon admission to hospital in …
News

Researchers find molecular treatment works against metastatic cancer spread to the brain

February 11, 2022 Medical Communications

According to a study published in Clinical Cancer Research, scientists at Mount Sinai conducting clinical trials of a drug targeting …
News

NICE recommends new combination for untreated advanced kidney cancer

February 4, 2022 Medical Communications

Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence (NICE) has issued a Final …
News

NICE issues FAD for Forxiga in adults with chronic kidney disease

February 4, 2022 Medical Communications

NICE has issued a Final Appraisal Document (FAD) recommending Forxiga (dapagliflozin) within its marketing authorisation for the treatment of adults …
News

Emmes supports new collaboration to advance COVID-19 research for children

February 4, 2022 Medical Communications

Clinical research organisation, Emmes, announced its role as a Data Coordinating Center on a team whose work has accelerated paediatric …
News

Measles jab rate in England falls to ten percent below recommended rate

February 1, 2022 Medical Communications

Over one in 10 school entry-age children in England are at risk of measles due to not receiving their vaccine …
News

RDIF, AstraZeneca and others invest in treatments for resistant arterial hypertension

February 1, 2022 Medical Communications

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), AstraZeneca, and Unicorn Capital Partners, a biotech-specialised VC fund, announced …
News

Supplemental NDA accepted for leukaemia treatment in China

January 28, 2022 Medical Communications

BeiGene, focused on developing innovative and affordable medicines, announced that the Center for Drug Evaluation (CDE) of the China National …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026